Stopping cancer in its tracks?

August 27, 2013 by Tracey Peake, North Carolina State University
Stopping cancer in its tracks?

We've come a long way in cancer treatments – we have powerful, effective drugs for many types of cancer and we're moving toward ever more specific, less invasive therapies. But the problem with cancer is that it's always in motion, metastasizing and spreading throughout the body to overwhelm it. What if you could stop cancer in its tracks?

Ken Adler, a at NC State, may be on to a way to do just that. Adler, who studies cell movement in like and asthma, developed a peptide, or small , that stopped inflammation by inhibiting the movement of .

As it turns out, that peptide, called the MANS peptide (for Myristoylated Alanine-Rich N-terminus sequence, if you were wondering), looks like it may also be effective in stopping the movement of other cells, like lung-cancer cells.

In collaboration with a team of scientists from UC Davis including researcher Reen Wu, Adler showed that the MANS peptide stopped lung-cancer cells from moving, or metastasizing, in mice. Their research results appear in the journal Oncogene.

So how, exactly, does a peptide stop a cell from moving?

Adler has spent a very long time looking at a particular protein known as MARCKS (or Myristoylated Alanine-rich C Kinase Substrate) and its involvement in cell movement. When MARCKS is activated, it binds to the cell's cytoskeleton (the scaffolding inside a cell), and specifically to a protein called actin, which contracts, as well as to the inside of the cell membrane. MARCKS links the actin and the membrane so that actin's movement translates into cell movement.

MANS works by binding to the membrane at the sites that MARCKS would normally use, crowding MARCKS out. The actin is still doing its job, but the link between the actin and the membrane is broken and the cell stays put.

Adler plans to continue studying the mechanisms that make MARCKS work, as well as the effects of the MANS peptide on metastasis. "Once we get to the basic mechanism of MARCKS, we'll have a lot of tools at our disposal to use in treating cancer, as well as other diseases," he says.

Explore further: Spread of cancer cells may be slowed by targeting of protein

Related Stories

Spread of cancer cells may be slowed by targeting of protein

December 18, 2012
(Medical Xpress)—The spread of cancer cells may be slowed by targeting the protein km23-1, according to researchers at Penn State College of Medicine.

Researchers aim to target achilles' heel of moving cancer cells

June 24, 2013
Cancer Research UK scientists are shedding new light on cancer spread – which could help in the development of new treatments for patients according to a study published in Nature Cell Biology.

Activity of cancer inducing genes can be controlled by the cell's skeleton

May 6, 2013
Cancer is a complex disease, in which cells undergo a series of alterations, including changes in their architecture; an increase in their ability to divide, to survive and to invade new tissues or metastasis. A category ...

Recommended for you

More than 2,500 cancer cases a week could be avoided

March 23, 2018
More than 135,500 cases of cancer a year in the UK could be prevented through lifestyle changes, according to new figures from a Cancer Research UK landmark study published today.

Metastatic lymph nodes can be the source of distant metastases in mouse models of cancer

March 22, 2018
A study by Massachusetts General Hospital (MGH) investigators finds that, in mouse models, cancer cells from metastatic lymph nodes can escape into the circulation by invading nodal blood vessels, leading to the development ...

Could a pap test spot more than just cervical cancer?

March 22, 2018
Pap tests have helped drive down rates of cervical cancer, and a new study suggests they also could be used to detect other gynecologic cancers early.

Researchers identify compound to prevent breast cancer cells from activating in brain

March 22, 2018
Researchers at Houston Methodist used computer modeling to find an existing investigational drug compound for leukemia patients to treat triple negative breast cancer once it spreads to the brain.

Researchers examine role of fluid flow in ovarian cancer progression

March 22, 2018
New research from Virginia Tech is moving physicians closer to pinpointing a predictor of ovarian cancer, which could lead to earlier diagnosis of what is know as the "silent killer."

Probing RNA epigenetics and chromatin structures to predict drug resistance in leukemia

March 22, 2018
Drug resistance is a major obstacle to effective treatment for patients with cancer and leukemia. Epigenetic modifying drugs have been proven effective for some patients with hematologic malignancies, such as myelodysplastic ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Aug 27, 2013
A drug blocking a path of one of the hallmarks of cancer, tissue invasion and metastasis, would be a very good news. http://en.wikiped...f_cancer

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.